About Thrombolex
Thrombolex is a private company based in Kingston, New Jersey. It has reported $55,631,251 raised in six offerings on Form D since April 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Mar 12, 2026 | $32,775,000of $51.1M target | 22 | $1.4M | Equity, Includes Conversion of Outstanding NotesRule 506(b) | Form D ↗ |
| Jun 4, 2024 | Jun 21, 2024 | $1,160,000of $5.0M target | 5 | $232K | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 1, 2023 | May 28, 2024 | $4,839,829fully sold | 56 | $86,426 | EquityRule 506(b) | Form D ↗ |
| Jul 28, 2022 | Aug 30, 2022 | $2,015,761fully sold | 50 | $40,315 | EquityRule 506(b) | Form D ↗ |
| Nov 15, 2021 | Nov 29, 2021 | $5,020,779fully sold | 46 | $109K | EquityRule 506(b) | Form D ↗ |
| Apr 6, 2017 | Apr 17, 2017amended Feb 3, 2020 | $9,819,882target not set | 33 | $297K | Debt, Convertible Promissory NoteRule 506(b) | Form D/A ↗2 earlier filings |
| Total, six offerings | $55,631,251 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Thrombolex's Form D filed Mar 12, 2026.
Earlier filings also listed Tony Litwiller (executive officer, last listed Jun 2024), Todd Richmond (director, last listed Jun 2024), Kelly Elliott (director, last listed Jun 2024) and Brian Firth (executive officer and director, last listed Aug 2022).